2 Υποκαλιαιμία-Υπερκαλιαιμία
DESCRIPTION
Διαταραχες τις συγκεντρωσεις του καλιουTRANSCRIPT
-
--
. .
-
--
3.53.5--5 5 mEqmEq/L (/L (mmolmmol/L)/L)
++ < 3.5 < 3.5 mEqmEq/L /L
++ > 5 > 5 mEqmEq/L /L
-
--
TMP: TMP: // [[KK++]] :: 3838//11 -- KK++: ~: ~--67mV, Na67mV, Na++/K/K++ ATPaseATPase --3mV, 3mV, ((. . Ca)Ca)
2
-
--
++//++ ATPaseATPase
--
--
-
::
[[KK++]] [[KK++]] --
//
-
RelationRelation betweenbetween serumserum KK++ andand thethe magnitudemagnitude ofofKK++ depletiondepletion
-
--
100 mEq [K+]
65 mEq
90-95 mEq 5-10 mEq
~250
~2500
~250
~300
-
[[++] ] (( ))
(( //))
-
// [[ pHpH ] ] [[HH++]] , [, [KK++]]
-- ((, , ) )
(( ++//++ATPaseATPase ) )
(( 12 12 ))
-
(( ))
(( ))
(( / /
) )
(( ))
-
(( :: 5% 5% ) ) [[KK++]] ((22 ))
BartterBartterss GitelmanGitelmanss (( HenleHenle / / . . ))
(( 1111-- , , LiddleLiddless))
-
((--, , ) )
-- (( ) )
(( B, B, ))
(( ..))
-
HCO3-15 mmol/l
15 %
60 %
HCO3-18 mmol/l
pH 6.5
HCO3-26 mmol/l
pH 7.8pH 5.5
-
H+
H2O
3HCO3- CO2 + OH-CA
Na+
3Na+Na+-K
ATPase2K+
H+ATPase
HCO3- + H+
H2CO3
Na+
H+
H2O
HCO3-
OH- + CO2
CA
Cl-
CO2 + H2O
CA
-
-- (( ,, ))-- -- :: < 3< 3mEqmEq/L/L(( , , UU, , QTQT))
-- (( , , , , ) )
-- ,,, , -- (( ) )
-- , ,
-
(())-- RBFRBF GFR GFR (( ))-- ((, , ) ) -- ADHADH--
((), ), , , -- (( , , ++ATPaseATPase) )
-- (( ))-- (( ) )
-- (( GH receptors, IGFGH receptors, IGF--11) )
-
2424
++ < 20< 20mEq(mmolmEq(mmol)/day:)/day: ,,
:: (())
pHpH:: , ,
:: (())
-
++ > 20> 20mEq(mmolmEq(mmol)/day: )/day:
:: (10mEq/dmEq/d):): ((. . Cushing, Cushing, . . LiddleLiddle) ) ((
)) ((, , , , . . BartterBartter, , GitelmanGitelman))
::
-
HypokalemiaHypokalemia and Hypertension and Hypertension
Urine KUrine K++ excretionexcretion
< 25 < 25 mEq/dmEq/d
Plasma Plasma reninrenin activityactivity
> 30mEq/d> 30mEq/d
High or normalHigh or normal
Continued diuretic useContinued diuretic useRenovascularRenovascular HTNHTNMalignant HTNMalignant HTNReninRenin--secreting tumorsecreting tumorCushingCushings Syndromes Syndrome
LowLow
Plasma Plasma aldosteronealdosterone
LowLowHighHigh
Primary Primary HyperaldosteronismHyperaldosteronism LicoriceLicoriceLiddleLiddlessSAMESAMEOther Other MineraloMineralo--
corticoidcorticoid
Adrenal vein Adrenal vein aldoaldo +/+/-- CTCT
Adenoma:Adenoma:Do surgeryDo surgery
Hyperplasia:Hyperplasia:KK++ sparing diureticsparing diuretic
GI losses GI losses Prior diuretic RxPrior diuretic Rx
-
TranstubularTranstubular potassium potassium grandientgrandient (TTKG)(TTKG)
< 2 = < 2 = (( ) ) > 4 = > 4 =
-
((, , , , , , ) ) :: (( 1010mEqmEq/hr /hr 40 40 mEqmEq/L/L))
1 1 amp KCL amp KCL 13mEq13mEq
-
(( , , ))::
((, , )):: NaClNaCl
((, , ))
-
(( ))
[[++] ] -- (( ))
[[++] ] (( ))
: : 1.31.3--10%10% (33(33--83% 83% )) (35(35--75%)75%)
-
--
(( [[KK++]] ))
, , (( > 50000 > 50000 mmmm33) ) (( >750000>750000 mmmm33))
(() )
-
--
-- ++ -- (( ) )
, ,
-
(( GFR < 25 ml/minGFR < 25 ml/min))
[[KK++] ] , , , ,
-
(( V)V)
(( 5050--75% 75% ))
((CrClCrCl 2020--75 ml/min75 ml/min))
50% 50% (( ))
((--, , NSAIDsNSAIDs,, ,,TacrolimusTacrolimus))
-
, ,
2020--40mg 40mg
TTKG (TTKG ( >7 >7 ,
-
--
++ , , , ,
--..
:: ++ < 10 < 10 mEqmEq/L /L ++ < 40 < 40 mEqmEq/L /L
-
(( ))-- -- , , --
-- , , QRSQRS--
(( ))::-- -- -- --
-
-- -- --
-
, , --
11-- ((. . ) )
--
-
(( )) (monitoring)(monitoring)
IVIV ((1010--30 30 .. 10%)10%)(( , , 3030--60 60 ))
[[KK++] ] -- --
(50 (50 grgr 10 10 ++ 0.60.6--1 1 mEqmEq/L/L, , 30 30 ))
-- / / NaHCO3NaHCO3 (50(50--150 150 mEqmEq, 1, 1--3 3 FlaconFlacon))
-- 22-- (( 90 90 , , 0.50.5--1 1 mEqmEq/L)/L)
-
(( ))
[[KK++] ] ((
1.3 1.3 mEqmEq/L /L 1 1 )) [K[K++]] -- KayexalateKayexalate (1(1grgr 0.60.6--1 1 mEqmEq KK++ ))(( 11--22hh , max 4, max 4--66 hh,, ++ 11mEqmEq/L /L 2424hh ))
++ > 6 > 6 mEqmEq/L /L
-
2 g/day2 g/day
((NSAIDsNSAIDs, , --))
, , , , kayexalatekayexalate
- - - - Relation between serum K+ and the magnitude of K+ depletion - Hypokalemia and Hypertension Transtubular potassium grandient (TTKG) - - ( V)